Q13526 (PIN1_HUMAN) Homo sapiens (Human)

Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 UniProtKBInterProSTRINGInteractive Modelling

163 aa; Sequence (Fasta) ; 13 identical sequences

Available Structures

118 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
SOLUTION STRUCTURE OF PIN1 WW DOMAIN COMPLEXED WITH CDC25 PHOSPHOTHREONINE PEPTIDE
1i8g
 Heteromer
P30311; 		6-44
Assess
SOLUTION STRUCTURE OF PIN1 WW DOMAIN COMPLEXED WITH HUMAN TAU PHOSPHOTHREONINE PEPTIDE
1i8h
 Heteromer
P10636; 		6-44
Assess
Structure of the WW domain of PIN1 in complex with a human phosphorylated Smad3 derived peptide
2lb3
 Heteromer
Q15796; 		6-41
Assess
PIN1 WW domain in complex with a phosphorylated CPEB1 derived peptide
2n1o
 Heteromer
Q9BZB8; 		7-39
Assess
14-3-3 sigma in complex with Pin1 binding site pS72 and covalently bound TCF521-026
7axn
 Heteromer
P31947; 		68-76
2×S6B; 8×CA; 2×CL;
Assess
14-3-3 sigma in complex with Pin1 binding site pS72
7aog
 Heteromer
P31947; 		68-76
4×CA; 4×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1012
7bgv
 Heteromer
P31947; 		69-77
2×TLK; 2×CA; 2×CL; 2×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound PC2046
7bg3
 Heteromer
P31947; 		68-75
2×TKK; 2×CA; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound PC2068A
7bfw
 Heteromer
P31947; 		68-75
2×TKH; 2×CA; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound PC2068B
7bdy
 Heteromer
P31947; 		68-75
2×TJK; 2×CA; 2×CL; 2×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1014
7az2
 Heteromer
P31947; 		69-75
2×SFW; 4×CA; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1013
7az1
 Heteromer
P31947; 		69-75
2×SGH; 4×CA; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound TCF521-011
7nif
 Heteromer
P31947; 		69-75
2×P5N; 4×CA; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1017
7bdp
 Heteromer
P31947; 		69-75
2×TJB; 2×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1019
7bgq
 Heteromer
P31947; 		69-75
2×TL8; 6×CA; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1009
7bdt
 Heteromer
P31947; 		69-75
2×TJ8; 2×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound TCF521-110
7ayf
 Heteromer
P31947; 		69-75
2×S9E; 2×CA;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1016
7bgr
 Heteromer
P31947; 		69-75
2×TQK; 2×CA; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1032
7nrl
 Heteromer
P31947; 		69-75
6×UPK; 4×GOL; 4×PEG; 2×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1007
7nj8
 Heteromer
P31947; 		69-75
2×JFS; 2×CA; 2×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1011
7bgw
 Heteromer
P31947; 		69-75
2×TLQ; 4×CA; 2×CL; 2×NA;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1008
7nig
 Heteromer
P31947; 		69-75
2×UFH; 4×CA; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1005
7nj6
 Heteromer
P31947; 		69-74
2×UG5; 2×CA;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound CV1040
8c2g
 Heteromer
P31947; 		69-74
2×T85; 4×MG;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1006
7nja
 Heteromer
P31947; 		69-74
2×UG2; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1002F1
7nrk
 Heteromer
P31947; 		69-74
2×UPQ; 2×CA; 2×CL; 4×PEG;
Assess
Ternary complex of 14-3-3 sigma, Pin1pS72 phosphopeptide, and WQ162
7oqa
 Heteromer
P31947; 		69-74
4×09W; 2×CL;
Assess
Ternary complex of 14-3-3 sigma, Pin1pS72 phosphopeptide, and WQ136
7oq9
 Heteromer
P31947; 		69-74
6×0AW; 2×CL;
Assess
14-3-3 sigma with Pin1 binding site pS72 and bound Fusicoccin A
8c3c
 Heteromer
P31947; 		69-73
2×FSC; 2×MG;
Assess
PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FROM HOMO SAPIENS
1pin
homo-2-mer6-163
2×ALA; 2×PRO; 2×SO4; 4×1PG;
Assess
human Pin1 Fip mutant
2f21
monomer1-163
2×1PE;
Assess
STRUCTURAL BASIS FOR THE PHOSPHOSERINE-PROLINE RECOGNITION BY GROUP IV WW DOMAINS
1f8a
monomer1-163
Assess
Solution structure of human Pin1
1nmv
monomer1-163
Assess
Two-state solution NMR structure of Apo Pin1
7sa5
monomer1-163
Assess
Two-state solution NMR structure of Pin1 bound to peptide FFpSPR
7suq
monomer1-163
Assess
Two-state solution NMR structure of Pin1 bound to peptide pCDC25c
7sur
monomer1-163
Assess
Crystal Structure Analysis of human PIN1
6vaj
monomer6-163
1×QT7; 2×SO4; 1×PG4;
Assess
Crystal structure of a mutant PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE
2zqt
monomer6-163
1×SO4; 1×1PG;
Assess
Crystal Structure Analysis of PIN1
6o34
monomer6-163
1×2PE; 1×GOL; 1×SO4;
Assess
Human Pin1 with cysteine sulfonic acid 113
4u86
monomer6-163
1×1PG;
Assess
Crystal Structure Analysis of PIN1
6o33
monomer6-163
1×SO4;
Assess
Human Pin1 complexed with reduced amide inhibitor
3ntp
monomer6-163
1×RZD; 1×PE8;
Assess
Prolyl isomerase Pin1 R14A mutant bound with Brd4 peptide
5uy9
monomer6-163
1×PE4; 2×SO4;
Assess
Structural and functional insights of directly targeting Pin1 by Epigallocatechin-3-gallate
3oob
monomer6-163
1×SO4; 3×PE4; 2×KDH;
Assess
Structure-guided design of alpha-amino acid-derived Pin1 inhibitors
3kce
monomer6-163
1×12P; 1×4BY;
Assess
Crystal Structure of human Pin1 complexed with a potent covalent inhibitor
7f0m
monomer6-163
1×0BF; 1×P33;
Assess
Crystal structure of a mutant PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE
2zqs
monomer6-163
1×SO4; 1×1PG;
Assess
Crystal Structure of human Pin1 complexed with a covalent inhibitor
7ekv
monomer6-163
1×J50; 1×PE8;
Assess
Crystal Structure Analysis of human PIN1
7efj
monomer6-163
1×J2C; 1×PE8;
Assess
Crystal structure of a mutant PIN1 peptidyl-prolyl cis-trans isomerase
2zr4
monomer6-163
1×1PG; 1×SO4;
Assess
Human Pin1 bound to cis peptidomimetic inhibitor
3tcz
monomer6-163
1×R2Z; 1×PE4;
Assess
Human Pin1 bound to trans peptidomimetic inhibitor
3tdb
monomer6-163
1×3TB; 1×PE4;
Assess
Crystal Structure of human PIN1 complexed with covalent inhibitor
7efx
monomer6-163
1×J3X;
Assess
Crystal structure of a mutant PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE
2zqv
monomer6-163
1×SO4; 1×1PG;
Assess
Crystal structure of a mutant PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE
2zqu
monomer6-163
1×SO4;
Assess
Crystal structure of a mutant PIN1 peptidyl-prolyl cis-trans isomerase
2zr5
monomer6-163
1×SO4; 1×1PG;
Assess
Crystal structure of a mutant PIN1 peptidyl-prolyl cis-trans isomerase
2zr6
monomer6-163
1×SO4; 1×1PG;
Assess
Selective targeting of disease-relevant protein binding domains by O-phosphorylated natural product…
3tc5
monomer7-163
1×3T5; 1×P6G;
Assess
human Pin1 bound to D-PEPTIDE
2itk
monomer7-163
1×PE4;
Assess
human Pin1 bound to L-PEPTIDE
2q5a
monomer7-163
1×16P;
Assess
Structure of Pin1 Complex with 18-crown-6
3wh0
monomer7-163
1×SO4; 2×O4B; 1×DTT;
Assess
Human Pin1 with cysteine sulfinic acid 113
4u85
monomer7-163
1×15P;
Assess
Human Pin1 with S-hydroxyl-cysteine 113
4u84
monomer7-163
1×15P;
Assess
DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION
2xp4
monomer7-163
1×12P; 1×G14;
Assess
Oxidation-Mediated Inhibition of the Peptidyl-Prolyl Isomerase Pin1
4qib
monomer7-163
1×PE4; 4×SO4;
Assess
DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION
2xp5
monomer7-163
1×12P; 1×4FF;
Assess
Structure-guided design of alpha-amino acid-derived Pin1 inhibitors
3kai
monomer7-163
1×12P; 1×4FI;
Assess
DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION
2xp6
monomer7-163
1×12P; 1×4G2;
Assess
human Pin1 Ng mutant
1zcn
monomer7-163
1×PO4; 2×1PE;
Assess
DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION
2xp9
monomer7-163
1×12P; 1×4G8;
Assess
Structure-guided design of alpha-amino acid-derived Pin1 inhibitors
3kag
monomer7-163
1×4D7; 1×12P;
Assess
DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION
2xpa
monomer7-163
1×12P; 1×4G5;
Assess
Structure-guided design of alpha-amino acid-derived Pin1 inhibitors
3kad
monomer7-163
1×4C0; 1×12P;
Assess
DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION
2xp7
monomer7-163
1×4F8; 1×12P;
Assess
DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION
2xpb
monomer7-163
1×12P; 1×4GE;
Assess
DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION
2xp3
monomer7-163
1×12P; 1×B21;
Assess
DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION
2xp8
monomer7-163
1×12P; 1×4FY;
Assess
Structure-guided design of alpha-amino acid-derived Pin1 inhibitors
3kab
monomer7-163
1×12P; 1×SO4; 1×4BL;
Assess
Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution
3odk
monomer7-163
1×PE4; 1×ODK;
Assess
Structure-guided design of alpha-amino acid-derived Pin1 inhibitors
3kaf
monomer7-163
1×4D9;
Assess
Structure-guided design of alpha-amino acid-derived Pin1 inhibitors
3kah
monomer7-163
1×12P; 1×4DH;
Assess
Crystal Structure Analysis of PIN1
6dun
monomer49-163
1×TAS;
Assess
Solution structure of the PPIase domain of human Pin1
1nmw
monomer50-163
1×SO4;
Assess
Structure-Based Design of Novel PIN1 Inhibitors (II)
3i6c
monomer51-163
2×GIA;
Assess
Structure of Pin1 PPIase domain bound with all-trans retinoic acid
4tns
monomer51-163
1×REA;
Assess
PPIase in complex with a non-phosphate small molecule inhibitor.
4tyo
monomer51-163
1×39X; 1×GOL;
Assess
Structure-Based Design of Novel PIN1 Inhibitors (I)
3ik8
monomer51-163
Assess
Structure-Based Design of Novel PIN1 Inhibitors (I)
3ikg
monomer51-163
1×J8Z;
Assess
Structure-Based Design of Novel PIN1 Inhibitors (II)
3jyj
monomer51-163
1×JZI;
Assess
Structure-Based Design of Novel PIN1 Inhibitors (I)
3ikd
monomer51-163
1×J9Z;
Assess
Structure-guided design of alpha-amino acid-derived Pin1 inhibitors
3kac
monomer51-163
1×4BX;
Assess
solution structure of human Pin1 PPIase mutant C113A
2ruq
monomer51-163
Assess
Solution structure of the peptidyl prolyl cis-trans isomerase domain of human Pin1 with sulfate ion
2ruc
monomer51-163
Assess
Solution structure of Human Pin1 PPIase C113S mutant
2rur
monomer51-163
Assess
Solution structure of the peptidyl prolyl cis-trans isomerase domain of C113D mutant human Pin1 wit…
2rud
monomer51-163
Assess
Solution structure of the Pin1-PPIase (S138A) mutant
5gph
monomer51-163
Assess
Structure of Pin1 WW domain
2m8i
monomer1-39
Assess
Structure of Pin1 WW domain phospho-mimic S16E
2m8j
monomer1-39
Assess
SOLUTION STRUCTURE OF PIN1 WW DOMAIN
1i6c
monomer6-44
Assess
Crystal structure of hPin1 WW domain (5-39) fused with maltose-binding protein
5b3z
monomer5-39
1×GLC;
Assess
NMR solution structure of Pin1 WW domain variant 6-1
2m9i
monomer6-39
Assess
NMR solution structure of Pin1 WW domain mutant 6-1g
2m9j
monomer6-39
1×NAG;
Assess
Protein allostery of the WW domain at atomic resolution: apo structure
6svc
monomer6-39
Assess
NMR solution structure of Pin1 WW domain mutant 5-1g
2m9f
monomer6-39
1×NAG;
Assess
Protein allostery of the WW domain at atomic resolution: pCdc25C bound structure
6sve
monomer6-39
Assess
NMR solution structure of Pin1 WW domain mutant with beta turn mimic at position 12
2kbu
monomer6-39
Assess
The NMR solution structure of the isolated Apo Pin1 WW domain
2kcf
monomer6-39
Assess
Protein allostery of the WW domain at atomic resolution: FFpSPR bound structure
6svh
monomer6-39
Assess
NMR solution structure of Pin1 WW domain mutant 5-1
2m9e
monomer6-39
Assess
Structure of Pin1 WW Domain Sequence 1 Substituted with [S,S]ACPC
5vtj
monomer6-38
2×SO4;
Assess
Structure of Pin1 WW Domain Sequence 3 with [R,R]-ACPC Loop Substitution
5vti
monomer6-38
1×CL;
Assess
Structure of Pin1 WW Domain Variant 1 with beta3-Ser Loop Substitution
5vtk
monomer6-38
4×CL;
Assess
Structure of racemic Pin1 WW domain cocrystallized with DL-malic acid
4gwt
monomer6-38
1×LMR;
Assess
Structure of racemic Pin1 WW domain cocrystallized with tri-ammonium citrate
4gwv
monomer6-38
1×FLC;
Assess
Crystal structure of hPin1 WW domain (5-21) fused with maltose-binding protein
5bmy
monomer5-21
1×GLC;
Assess
Crystal structure of hPin1 WW domain (5-23) fused with maltose-binding protein
5b3y
monomer11-23
1×GLC;
Assess
Crystal structure of hPin1 WW domain (5-15) fused with maltose-binding protein in C2221 form
5b3w
monomer5-15
1×GLC;
Assess
Crystal structure of hPin1 WW domain (5-15) fused with maltose-binding protein in P41212 form
5b3x
monomer7-15
1×GLC;
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2zr4.1.Amonomer0.826-163
99.39
Assess
1nmv.1.Amonomer0.691-163
100.00
Assess
7suq.1.Amonomer0.551-163
100.00
Assess
7sa5.1.Amonomer0.541-163
100.00
Assess